CAS: 851095-32-4 - STX-0119
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
STX-0119 REF: TM-T60160CAS: 851095-32-4 | 99.42% | A consultar | Jue 09 Ene 25 | |
N-[5-(2-Furanyl)-1,3,4-oxadiazol-2-yl]-2-phenyl-4-quinolinecarboxamide REF: TR-F863670CAS: 851095-32-4 | - - - | 1.063,00 € | Mar 18 Feb 25 | |
N-[5-(Furan-2-yl)-1,3,4-oxadiazol-2-yl]-2-phenylquinoline-4-carboxamide REF: 3D-BJB09532CAS: 851095-32-4 | Min. 95% | - - - | Producto descatalogado |
STX-0119
CAS:851095-32-4
STX-0119 is a selective, orally active STAT3 dimerization inhibitor. STX-0119 inhibits STAT3 transcription with an …
Fórmula:
C22H14N4O3
Pureza:
99.42%
Forma y color:
Liquid
Peso molecular:
382.37
Ref: TM-T60160
5mg | 63,00 € | ||
10mg | 90,00 € | ||
25mg | 174,00 € | ||
50mg | 277,00 € | ||
100mg | 417,00 € | ||
500mg | A consultar | ||
1mL*10mM (DMSO) | 63,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Enero de 2025
N-[5-(2-Furanyl)-1,3,4-oxadiazol-2-yl]-2-phenyl-4-quinolinecarboxamide
Producto controladoCAS:851095-32-4
Fórmula:
C22H14N4O3
Forma y color:
Neat
Peso molecular:
382.37
Ref: TR-F863670
100mg | 1.063,00 € |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
N-[5-(Furan-2-yl)-1,3,4-oxadiazol-2-yl]-2-phenylquinoline-4-carboxamide
CAS:851095-32-4
Please enquire for more information about N-[5-(Furan-2-yl)-1,3,4-oxadiazol-2-yl]-2-phenylquinoline-4-carboxamide including the price, delivery time and more detailed …
Fórmula:
C22H14N4O3
Pureza:
Min. 95%
Peso molecular:
382.4 g/mol
Ref: 3D-BJB09532
Tamaño no definido | Descatalogado | Solicitar información | |
5mg | Descatalogado | Solicitar información | |
10mg | Descatalogado | Solicitar información | |
25mg | Descatalogado | Solicitar información | |
50mg | Descatalogado | Solicitar información | |
100mg | Descatalogado | Solicitar información |